查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1842313

全球梅毒检测市场：市场规模、份额、趋势分析（按技术、检测地点和地区划分）、细分市场预测（2025-2033 年）

Syphilis Testing Market Size Share & Trends Analysis Report By Technology (Molecular Diagnostics, Immunoassay), By Location of Testing (Laboratory Testing, Point Of Care Testing), By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 236 Pages | 商品交期: 2-10个工作天内

价格

梅毒检测：市场概览

全球梅毒检测市场预计在 2024 年达到 5.1521 亿美元，预计到 2033 年将达到 13.756 亿美元，2025 年至 2033 年的复合年增长率为 11.89%。

HIV/梅毒双重快速诊断的主要市场驱动因素是先天性梅毒和 HIV 合併感染在全球日益严重的负担，这继续对怀孕产生重大不利影响。

世界卫生组织和各国卫生部门日益重视消除母婴传播（EMTCT）项目，这催生了对经济高效的即时检测（PoC）解决方案的强劲需求。加拿大卫生署批准MedMira公司的Multiplo快速TP/HIV检测等监管核准，以及CHAI-MedAccess-SD生物感测器等伙伴关係，透过确保价格可承受性和可及性，加速了即时检测解决方案的普及应用。核准，在农村和医疗服务不足地区推行分散式检查也推动了即时检测解决方案的广泛应用，而检测准确性和速度的技术进步则增强了市场信心。

梅毒曾被认为是一种过时的疾病，如今却在北美乃至全球范围内再次成为重要的公共卫生和市场问题。儘管20世纪中期青霉素的广泛应用几乎在高所得国家根除了梅毒，但近年来梅毒疫情迅速反弹。在美国，2018年至2022年间报告的梅毒病例增加了80%以上，从约11.5万例增至超过20.7万例，达到20世纪50年代以来的最高水准。尤其令人担忧的是先天性梅毒，同期病例增加了183%，反映出孕产妇筛检和早期疗育的差距。在加拿大，草原省份和北部地区的发病率上升进一步凸显了及时诊断和治疗方面存在的差距，尤其是在原住民群体中。这些流行病学变化正在催生对创新诊断解决方案、分散式检查模式和可扩展的公共卫生干预措施日益增长的需求，使感染疾病诊断市场加速成长。

目录

第一章 梅毒检测市场：分析方法与范围

2. 梅毒检测市场：执行摘要

  • 市场概述
  • 按技术和检查区域分類的简介
  • 按癌症类型和功能分類的简介
  • 竞争格局概览

3. 梅毒检测市场：影响因素、趋势与范围

  • 市场区隔及范围
  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 市场驱动因素分析
  • 市场限制因素分析
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第四章 梅毒检测市场：依技术分類的估算与趋势分析

  • 梅毒检测市场：依技术分類的差异分析
  • 分子诊断
  • 免疫检测
  • 其他的

第五章 梅毒检测市场：依检测点分類的估算与趋势分析

  • 梅毒检测市场：波动分析（依检测点划分）
  • 实验室测试
    • 商业/私人实验室
    • 公共卫生实验室
  • 照护现场侦测 (PoC)

6. 梅毒检测市场：按地区分類的业务分析

  • 市场概览：按地区划分
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第七章 竞争情势

  • 公司分类
  • 策略规划
    • 新产品上市
    • 商业伙伴关係
    • 企业收购
    • 商业合作
    • 资金筹措
  • 主要企业市占率分析（2024 年）
  • 公司热力图分析
  • 公司简介
    • Abbott Laboratories
    • Bio-Rad Laboratories, Inc.
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers AG
    • Danaher Corporation（Beckman Coulter）
    • bioMerieux SA
    • Thermo Fisher Scientific, Inc.
    • OraSure Technologies, Inc.
    • Chembio Diagnostics, Inc.
    • SD Biosensor, Inc.
Product Code: GVR-4-68040-747-4

Syphilis Testing Market Summary

The global syphilis testing market size was estimated at USD 515.21 million in 2024 and is projected to reach USD 1,375.60 million by 2033, growing at a CAGR of 11.89% from 2025 to 2033. Key market growth drivers for dual HIV/syphilis rapid diagnostics include the rising global burden of congenital syphilis and HIV co-infections, which continue to cause significant adverse pregnancy outcomes.

Growing emphasis on elimination of mother-to-child transmission (EMTCT) programs by the WHO and national health bodies is creating strong demand for cost-effective, point-of-care solutions. Regulatory approvals, such as Health Canada's clearance of MedMira's Multiplo Rapid TP/HIV Test, and partnerships like CHAI-MedAccess-SD Biosensor, are accelerating adoption by ensuring affordability and accessibility. Additionally, the push for decentralized testing in rural and underserved regions supports uptake, while technological improvements in accuracy and speed enhance market confidence.

Syphilis, once considered a disease of the past, has reemerged as a significant public health and market concern in North America and globally. While the widespread use of penicillin in the mid-20th century had nearly eliminated syphilis in high-income countries, recent years have seen a sharp resurgence. In the U.S., reported cases increased by more than 80% between 2018 and 2022, rising from approximately 115,000 to over 207,000-the highest level since the 1950s. Of particular concern is congenital syphilis, which grew by 183% during the same period, reflecting gaps in maternal screening and early intervention. In Canada, rising incidence in the Prairie provinces and northern territories-particularly among Indigenous populations further highlights disparities in access to timely diagnostics and treatment. These epidemiological shifts are creating heightened demand for innovative diagnostic solutions, decentralized testing models, and scalable public health interventions, positioning the infectious disease diagnostics market for accelerated growth.

Global Syphilis Testing Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global syphilis testing market report based on technology, location of testing, cancer type, function, and region:

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Molecular Diagnostics
  • Immunoassay
  • Others
  • Location of Testing Outlook (Revenue, USD Million, 2021 - 2033)
  • Laboratory Testing
    • Commercial/Private labs
    • Public Health Labs
  • Point of Care Testing
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Syphilis Testing Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Technology Segment
      • 1.1.1.2. Location of Testing Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Syphilis Testing Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Technology and Location of Testing Snapshot
  • 2.3. Cancer Type and Function Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. Syphilis Testing Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
  • 3.5. Market Restraint Analysis
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. Syphilis Testing Market: Technology Estimates & Trend Analysis

  • 4.1. Syphilis Testing Market: Technology Movement Analysis
  • 4.2. Molecular Diagnostics
    • 4.2.1. Molecular Diagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 4.3. Immunoassay
    • 4.3.1. Immunoassay Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Others
    • 4.4.1. Others Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Syphilis Testing Market: Location of Testing Estimates & Trend Analysis

  • 5.1. Syphilis Testing Market: Location of Testing Movement Analysis
  • 5.2. Laboratory Testing
    • 5.2.1. Laboratory Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.2. Commercial/Private labs
      • 5.2.2.1. Commercial/Private labs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.3. Public Health Labs
      • 5.2.3.1. Public Health Labs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3. Point of Care Testing
    • 5.3.1. Point of Care Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Syphilis Testing Market: Regional Business Analysis

  • 6.1. Regional Market Snapshot
  • 6.2. North America
    • 6.2.1. North America Syphilis Testing Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.2.2.2. Key Country Dynamics
      • 6.2.2.3. Regulatory Framework
      • 6.2.2.4. Reimbursement Scenario
      • 6.2.2.5. Competitive Scenario
    • 6.2.3. Canada
      • 6.2.3.1. Canada Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.2.3.2. Key Country Dynamics
      • 6.2.3.3. Regulatory Framework
      • 6.2.3.4. Reimbursement Scenario
      • 6.2.3.5. Competitive Scenario
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.2.4.2. Key Country Dynamics
      • 6.2.4.3. Regulatory Framework
      • 6.2.4.4. Reimbursement Scenario
      • 6.2.4.5. Competitive Scenario
  • 6.3. Europe
    • 6.3.1. Europe Syphilis Testing Market, 2021 - 2033 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.3.2.2. Key Country Dynamics
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. Reimbursement Scenario
      • 6.3.2.5. Competitive Scenario
    • 6.3.3. Germany
      • 6.3.3.1. Germany Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.3.3.2. Key Country Dynamics
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Reimbursement Scenario
      • 6.3.3.5. Competitive Scenario
    • 6.3.4. Spain
      • 6.3.4.1. Spain Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.3.4.2. Key Country Dynamics
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. Reimbursement Scenario
      • 6.3.4.5. Competitive Scenario
    • 6.3.5. France
      • 6.3.5.1. France Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.3.5.2. Key Country Dynamics
      • 6.3.5.3. Regulatory Framework
      • 6.3.5.4. Reimbursement Scenario
      • 6.3.5.5. Competitive Scenario
    • 6.3.6. Italy
      • 6.3.6.1. Italy Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.3.6.2. Key Country Dynamics
      • 6.3.6.3. Regulatory Framework
      • 6.3.6.4. Reimbursement Scenario
      • 6.3.6.5. Competitive Scenario
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.3.7.2. Key Country Dynamics
      • 6.3.7.3. Regulatory Framework
      • 6.3.7.4. Reimbursement Scenario
      • 6.3.7.5. Competitive Scenario
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.3.8.2. Key Country Dynamics
      • 6.3.8.3. Regulatory Framework
      • 6.3.8.4. Reimbursement Scenario
      • 6.3.8.5. Competitive Scenario
    • 6.3.9. Norway
      • 6.3.9.1. Norway Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.3.9.2. Key Country Dynamics
      • 6.3.9.3. Regulatory Framework
      • 6.3.9.4. Reimbursement Scenario
      • 6.3.9.5. Competitive Scenario
  • 6.4. Asia Pacific
    • 6.4.1. Asia-Pacific Syphilis Testing Market, 2021 - 2033 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.4.2.2. Key Country Dynamics
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Reimbursement Scenario
      • 6.4.2.5. Competitive Scenario
    • 6.4.3. China
      • 6.4.3.1. China Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.4.3.2. Key Country Dynamics
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Reimbursement Scenario
      • 6.4.3.5. Competitive Scenario
    • 6.4.4. India
      • 6.4.4.1. India Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.4.4.2. Key Country Dynamics
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Reimbursement Scenario
      • 6.4.4.5. Competitive Scenario
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.4.5.2. Key Country Dynamics
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Reimbursement Scenario
      • 6.4.5.5. Competitive Scenario
    • 6.4.6. Thailand
      • 6.4.6.1. Thailand Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.4.6.2. Key Country Dynamics
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Reimbursement Scenario
      • 6.4.6.5. Competitive Scenario
    • 6.4.7. Australia
      • 6.4.7.1. Australia Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.4.7.2. Key Country Dynamics
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. Reimbursement Scenario
      • 6.4.7.5. Competitive Scenario
  • 6.5. Latin America
    • 6.5.1. Latin America Syphilis Testing Market, 2021 - 2033 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.5.2.2. Key Country Dynamics
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement Scenario
      • 6.5.2.5. Competitive Scenario
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.5.3.2. Key Country Dynamics
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement Scenario
      • 6.5.3.5. Competitive Scenario
  • 6.6. MEA
    • 6.6.1. MEA Syphilis Testing Market, 2021 - 2033 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.6.2.2. Key Country Dynamics
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement Scenario
      • 6.6.2.5. Competitive Scenario
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.6.3.2. Key Country Dynamics
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement Scenario
      • 6.6.3.5. Competitive Scenario
    • 6.6.4. UAE
      • 6.6.4.1. UAE Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.6.4.2. Key Country Dynamics
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement Scenario
      • 6.6.4.5. Competitive Scenario
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.6.5.2. Key Country Dynamics
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement Scenario
      • 6.6.5.5. Competitive Scenario

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
    • 7.2.1. New Product Launch
    • 7.2.2. Partnerships
    • 7.2.3. Acquisition
    • 7.2.4. Collaboration
    • 7.2.5. Funding
  • 7.3. Key Company Market Share Analysis, 2024
  • 7.4. Company Heat Map Analysis
  • 7.5. Company Profiles
    • 7.5.1. Abbott Laboratories
      • 7.5.1.1. Company Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Bio-Rad Laboratories, Inc.
      • 7.5.2.1. Company Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. F. Hoffmann-La Roche Ltd
      • 7.5.3.1. Company Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Siemens Healthineers AG
      • 7.5.4.1. Company Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Danaher Corporation (Beckman Coulter)
      • 7.5.5.1. Company Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
    • 7.5.6. bioMerieux SA
      • 7.5.6.1. Company Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Thermo Fisher Scientific, Inc.
      • 7.5.7.1. Company Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. OraSure Technologies, Inc.
      • 7.5.8.1. Company Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Chembio Diagnostics, Inc.
      • 7.5.9.1. Company Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. SD Biosensor, Inc.
      • 7.5.10.1. Company Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America Syphilis Testing market, by country, 2021 - 2033 (USD million)
  • Table 4 North America Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 5 North America Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 6 U.S. Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 7 U.S. Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 8 Canada Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 9 Canada Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 10 Europe Syphilis Testing market, by country, 2021 - 2033 (USD million)
  • Table 11 Europe Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 12 Europe Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 13 UK Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 14 UK Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 15 Germany Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 16 Germany Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 17 France Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 18 France Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 19 Italy Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 20 Italy Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 21 Spain Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 22 Spain Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 23 Denmark Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 24 Denmark Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 25 Sweden Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 26 Sweden Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 27 Norway Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 28 Norway Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 29 Asia Pacific Syphilis Testing market, by country, 2021 - 2033 (USD million)
  • Table 30 Asia Pacific Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 31 Asia Pacific Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 32 China Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 33 China Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 34 Japan Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 35 Japan Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 36 India Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 37 India Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 38 South Korea Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 39 South Korea Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 40 Australia Syphilis Testing market, by technology 2021 - 2033 (USD million)
  • Table 41 Australia Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 42 Thailand Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 43 Thailand Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 44 Latin America Syphilis Testing market, by country, 2021 - 2033 (USD million)
  • Table 45 Latin America Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 46 Latin America Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 47 Brazil Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 48 Brazil Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 49 Mexico Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 50 Mexico Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 51 Argentina Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 52 Argentina Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 53 Middle East & Africa Syphilis Testing market, by country, 2021 - 2033 (USD million)
  • Table 54 Middle East & Africa Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 55 Middle East & Africa Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 56 South Africa Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 57 South Africa Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 58 Saudi Arabia Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 59 Saudi Arabia Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 60 UAE Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 61 UAE Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 62 Kuwait Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 63 Kuwait Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global Syphilis Testing market- Key market driver analysis
  • Fig. 7 Global Syphilis Testing market - Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Global Syphilis Testing market - Porter's analysis
  • Fig. 10 Global Syphilis Testing market - PESTEL analysis
  • Fig. 11 Global Syphilis Testing market technology outlook key takeaways
  • Fig. 12 Global Syphilis Testing market: Technology movement analysis
  • Fig. 13 Molecular Diagnostics market estimates, 2021 - 2033 (USD Million)
  • Fig. 14 Immunoassay market estimates, 2021 - 2033 (USD Million)
  • Fig. 15 Others market estimates, 2021 - 2033 (USD Million)
  • Fig. 16 Global Syphilis Testing market Location of Testing outlook key takeaways
  • Fig. 17 Global Syphilis Testing market: Location of Testing movement analysis
  • Fig. 18 Laboratory Testing market estimates, 2021 - 2033 (USD Million)
  • Fig. 19 Commercial/Private labs market estimates, 2021 - 2033 (USD Million)
  • Fig. 20 Public Health Labs market estimates, 2021 - 2033 (USD Million)
  • Fig. 21 Point of Care Testing market estimates, 2021 - 2033 (USD Million)
  • Fig. 22 Regional marketplace: Key takeaways
  • Fig. 23 Global Syphilis Testing market: Regional movement analysis
  • Fig. 24 North America Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 25 U.S. Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 26 Canada Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 27 Europe Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 28 UK Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 29 Germany Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 30 France Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 31 Spain Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 32 Italy Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 33 Denmark Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 34 Sweden Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 35 Norway Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 36 Asia Pacific Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 37 Japan Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 38 China Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 39 India Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 40 South Korea Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 41 Australia Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 42 Thailand Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 43 Latin America Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 44 Brazil Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 45 Mexico Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 46 Argentina Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 47 MEA Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 48 South Africa Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 49 Saudi Arabia Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 50 UAE Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 51 Kuwait Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 52 Strategy framework